Cargando…

Chronic exposure to dopamine agonists affects the integrity of striatal D(2) receptors in Parkinson's patients

We aimed to investigate the integrity and clinical relevance of striatal dopamine receptor type-2 (D(2)R) availability in Parkinson's disease (PD) patients. We studied 68 PD patients, spanning from early to advanced disease stages, and 12 healthy controls. All participants received one [(11)C]r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Politis, Marios, Wilson, Heather, Wu, Kit, Brooks, David J., Piccini, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577411/ https://www.ncbi.nlm.nih.gov/pubmed/28879087 http://dx.doi.org/10.1016/j.nicl.2017.08.013

Ejemplares similares

Processing speed is related to striatal dopamine transporter availability in Parkinson's disease
por: Vriend, Chris, et al.
Publicado: (2020)

Serotonergic dysregulation is linked to sleep problems in Parkinson's disease
por: Wilson, Heather, et al.
Publicado: (2018)

Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease
por: Picillo, Marina, et al.
Publicado: (2020)

Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia
por: Kubota, Manabu, et al.
Publicado: (2017)

Dopamine agonist treatment increases sensitivity to gamble outcomes in the hippocampus in de novo Parkinson’s disease
por: van der Vegt, Joyce P.M., et al.
Publicado: (2020)

Striatal Dopamine and Reward Prediction Error Signaling in Unmedicated Schizophrenia Patients
por: Katthagen, Teresa, et al.
Publicado: (2020)

Specificity of striatal dopamine D(1) system in humans: implications for clinical use of D(1) receptor-agonists in Parkinson's disease
por: Goto, Satoshi
Publicado: (2023)

The Dopamine Agonist Bromocriptine Differentially Affects Fronto-Striatal Functional Connectivity During Working Memory
por: Wallace, Deanna L., et al.
Publicado: (2011)

Ventral Striatal Dopamine Synthesis Capacity Predicts Financial Extravagance in Parkinson’s Disease
por: Lawrence, Andrew D., et al.
Publicado: (2013)

Striatal dopamine D(2)/D(3) receptor binding in pathological gambling is correlated with mood-related impulsivity
por: Clark, Luke, et al.
Publicado: (2012)

Lower (123)I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies
por: Joling, Merijn, et al.
Publicado: (2018)

[(18)F]fallypride characterization of striatal and extrastriatal D(2/3) receptors in Parkinson's disease
por: Stark, Adam J., et al.
Publicado: (2018)

Compensatory striatal–cerebellar connectivity in mild–moderate Parkinson's disease
por: Simioni, Alison C., et al.
Publicado: (2015)

Striatal shape alteration as a staging biomarker for Parkinson’s Disease()
por: Peralta, Maxime, et al.
Publicado: (2020)

Autonomic failure in Parkinson’s disease is associated with striatal dopamine deficiencies
por: van Deursen, Dagmar N., et al.
Publicado: (2020)

The Transfection of BDNF to Dopamine Neurons Potentiates the Effect of Dopamine D3 Receptor Agonist Recovering the Striatal Innervation, Dendritic Spines and Motor Behavior in an Aged Rat Model of Parkinson’s Disease
por: Razgado-Hernandez, Luis F., et al.
Publicado: (2015)

The treatment of Parkinson's disease with dopamine agonists
por: Konta, Brigitte, et al.
Publicado: (2008)

Putamen–midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases
por: Rieckmann, A., et al.
Publicado: (2015)

Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease
por: Fiorenzato, Eleonora, et al.
Publicado: (2021)

Probabilistic classification learning with corrective feedback is associated with in vivo striatal dopamine release in the ventral striatum, while learning without feedback is not
por: Wilkinson, Leonora, et al.
Publicado: (2014)

Dopamine-transporter levels drive striatal responses to apomorphine in Parkinson's disease
por: Passamonti, Luca, et al.
Publicado: (2013)

Gender Differences in Age-Related Striatal Dopamine Depletion in Parkinson’s Disease
por: Lee, Jae Jung, et al.
Publicado: (2015)

Altered functional connectivity associated with striatal dopamine depletion in Parkinson’s disease
por: Shima, Atsushi, et al.
Publicado: (2023)

Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients
por: Deutschländer, Angela, et al.
Publicado: (2016)

Striatal Dopamine Loss in Early Parkinson's Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging
por: Heng, Nicholas, et al.
Publicado: (2023)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009)

Fronto-striatal dopamine D2 receptor availability is associated with cognitive variability in older individuals with low dopamine integrity
por: Korkki, Saana M., et al.
Publicado: (2021)

Striatal Dopamine D(2) Receptor Occupancy Induced by Daily Application of Blonanserin Transdermal Patches: Phase II Study in Japanese Patients With Schizophrenia
por: Nishibe, Hironori, et al.
Publicado: (2020)

Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels
por: Voon, Valerie, et al.
Publicado: (2014)

Striatal Dopamine Depletion Patterns and Early Non-Motor Burden in Parkinsons Disease
por: Chung, Su Jin, et al.
Publicado: (2016)

Reduced striatal dopamine release during motor skill acquisition in Parkinson’s disease
por: Kawashima, Shoji, et al.
Publicado: (2018)

Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease
por: Caminiti, Silvia Paola, et al.
Publicado: (2017)

Striatal But Not Extrastriatal Dopamine Receptors Are Critical to Dopaminergic Motor Stimulation
por: Wang, Yuhan, et al.
Publicado: (2017)

Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease()
por: Schlaudraff, Falk, et al.
Publicado: (2014)

Imaging of Microglia in Patients with Neurodegenerative Disorders
por: Politis, Marios, et al.
Publicado: (2012)

Dopamine agonist monotherapy utilization in patients with Parkinson’s disease
por: Frazer, Monica, et al.
Publicado: (2022)

Reversal of pathological motor behavior in a model of Parkinson’s disease by striatal dopamine uncaging
por: Zamora-Ursulo, Miguel A., et al.
Publicado: (2023)

Longitudinal decline in striatal dopamine transporter binding in Parkinson’s disease: associations with apathy and anhedonia
por: Costello, Harry, et al.
Publicado: (2023)

Nonergot dopamine-receptor agonists for treating Parkinson’s disease – a network meta-analysis
por: Thorlund, Kristian, et al.
Publicado: (2014)

Cortical Control of Striatal Dopamine Transmission via Striatal Cholinergic Interneurons
por: Kosillo, Polina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4pkh1llcgc89n5479072clt354